The national protocol aimed to improve the outcome of the high risk neuroblastoma patients by high-dose chemotherapy and stem cell rescue with intensive multimodal therapy
BACKGROUND: The majority of patients with high risk neuroblastoma (NB) still relapse. PROCEDURE: We ...
Neuroblastoma is one of the commonest childhood cancers and typically affects very young children. I...
Neuroblastoma (NBL) is the most common extracranial solid tumor of childhood, with about 700 new cas...
Background: The national protocol aimed to improve the outcome of the high risk neuroblastoma patien...
Background: The national protocol aimed to improve the outcome of the high risk neuroblastoma patien...
The survival of patients with high-risk neuroblastoma has improved significantly with the use of int...
WOS: 000182134800004PubMed ID: 12637217This multicentric study aimed to bring neuroblastoma patients...
Neuroblastoma is the most common extracranial solid tumor in children. One subset, high-risk neurobl...
Twenty-two pediatric patients with a stage IV-A or IV-B neuroblastoma have been treated with multimo...
To determine the potential benefits and feasibility of administering maintenance therapy with dinutu...
PURPOSE: Advances in chemotherapy and supportive care have slowly improved survival rates for patien...
Objective: To present a case of high-risk, stage four neuroblastoma in a 20-year-old woman who survi...
Background: Relapsed/refractory high-risk neuroblastoma has a dismal prognosis. Anti-GD2-mediated ch...
Neuroblastoma is the most common extracranial solid tumor in children, accounting for 15% of all ped...
PurposeThe Chinese Children’s Cancer Group developed the CCCG-NB-2014 study to formulate optimal tre...
BACKGROUND: The majority of patients with high risk neuroblastoma (NB) still relapse. PROCEDURE: We ...
Neuroblastoma is one of the commonest childhood cancers and typically affects very young children. I...
Neuroblastoma (NBL) is the most common extracranial solid tumor of childhood, with about 700 new cas...
Background: The national protocol aimed to improve the outcome of the high risk neuroblastoma patien...
Background: The national protocol aimed to improve the outcome of the high risk neuroblastoma patien...
The survival of patients with high-risk neuroblastoma has improved significantly with the use of int...
WOS: 000182134800004PubMed ID: 12637217This multicentric study aimed to bring neuroblastoma patients...
Neuroblastoma is the most common extracranial solid tumor in children. One subset, high-risk neurobl...
Twenty-two pediatric patients with a stage IV-A or IV-B neuroblastoma have been treated with multimo...
To determine the potential benefits and feasibility of administering maintenance therapy with dinutu...
PURPOSE: Advances in chemotherapy and supportive care have slowly improved survival rates for patien...
Objective: To present a case of high-risk, stage four neuroblastoma in a 20-year-old woman who survi...
Background: Relapsed/refractory high-risk neuroblastoma has a dismal prognosis. Anti-GD2-mediated ch...
Neuroblastoma is the most common extracranial solid tumor in children, accounting for 15% of all ped...
PurposeThe Chinese Children’s Cancer Group developed the CCCG-NB-2014 study to formulate optimal tre...
BACKGROUND: The majority of patients with high risk neuroblastoma (NB) still relapse. PROCEDURE: We ...
Neuroblastoma is one of the commonest childhood cancers and typically affects very young children. I...
Neuroblastoma (NBL) is the most common extracranial solid tumor of childhood, with about 700 new cas...